17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone replacement therapy for preventing cardiovascular disease in post-menopausal womenTreatment of osteoporosis: current and future.Bones and Crohn's: problems and solutions.The effects of SERMs on the skeleton.Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.The replacement of oestradiol and progesterone in very premature infants.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995.Postmenopausal bone remodelling and hormone replacement.Effects of progestins on bone: an update.Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be usefulEffect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.[Osteoporosis in 1993. An information update].Endogenous sex hormones and bone mineral density among community-based postmenopausal women.HT update: spotlight on estradiol/norethindrone acetate combination therapyComparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal womenNovel actions of progesterone: what we know today and what will be the scenario in the future?The synthetic progestin, gestodene, affects functional biomarkers in neonatal rat osteoblasts through an estrogen receptor-related mechanism of action.Hormone-replacement therapy: current thinking.Pulsatile tinnitus in perimenopausal period.Estrogen therapy in women over 60 years of age.The menopause: health implications and clinical management.Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women.The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women.Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats.Biochemical aspects of hormonal contraception: effects on bone metabolism.A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin.Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study
P2860
Q24187326-E55C393E-047F-41AB-8112-22CE97A53881Q24244146-2E10E3D8-54D8-4D5E-BC8F-D64D59242B2EQ33563886-80FB6CE6-8B79-4FF8-8C70-73105B3C88ACQ33715520-55B2C9BA-5A2C-41A6-BF21-C64C2160FA4EQ33757731-A6A8DF7B-3730-476B-9BDD-C724AB07997FQ33909569-C2BAA112-7828-4524-90CC-34E51F2F0244Q34157543-6DD33B3B-E301-40AD-83C4-5265C91B3E2BQ34573282-B5A8944D-F652-4E1A-A34A-EC4DA92E5972Q34573300-19D26066-D6F6-496C-BA2B-CE82A86E64F1Q34573306-F05B6B6C-4F3E-422C-8C5A-6DD1D90C299AQ34847643-2F92E243-82F3-4945-8A90-1C1B985E287AQ35823544-9B93650B-9CC5-4022-9A43-30DA09D0C782Q35823749-31419E49-3FC0-4FF1-98AF-1BADDBDE3313Q36653023-C74A5FC4-2A5E-4876-A0B1-34FF3DBB942DQ36682931-4B94DD18-67D8-4D8F-B3C1-6CF9A03C754EQ36892918-6A244867-C033-45FF-99D4-9FFCB1718F4CQ37018947-F58D32D3-C951-45CD-817A-F55982FA85C5Q38024835-80AEE4E1-B69A-446C-8A09-E6735BA7016BQ38887127-AB2D2B55-40E8-420E-BDE2-7E974CF25BB5Q38975101-9E38A58F-1646-4527-AE8D-EE7BA3463CD2Q39980702-857B92CD-CE76-4671-8944-994C6C3C3971Q40586460-AF459D9C-0A9C-485A-99E8-17BEABEFCF49Q40892229-B65524BC-B569-4F01-9209-DD388999116DQ43856670-0E4301B0-5874-4130-9138-59F4E83C8492Q46958876-C7C39941-CA69-4D71-B99F-E21546655A2DQ47289352-1D48B4C9-CE8D-41BC-8A2B-E71E71DD1D65Q47790903-4B2FEA1A-88B8-44F2-B620-CB152AA2661AQ51580931-107765CD-D738-40D1-B702-36C73B5AD3E3Q59315936-17432A28-ABB5-4525-9B04-50E35AA16D0C
P2860
17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
name
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@ast
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@en
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@nl
type
label
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@ast
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@en
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@nl
prefLabel
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@ast
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@en
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@nl
P356
P1476
17 Beta-estradiol and continuo ...... osteoporosis in elderly women.
@en
P2093
Christiansen C
P304
P356
10.1210/JCEM-71-4-836
P407
P577
1990-10-01T00:00:00Z